Parotidectomy in children: indications and complications

2010 ◽  
Vol 124 (12) ◽  
pp. 1289-1293 ◽  
Author(s):  
C Meiling Xie ◽  
H Kubba

AbstractBackground:Parotidectomy in children is uncommon, and surgeons face specific challenges not encountered in adult practice.Method:Retrospective review of parotidectomies performed in our paediatric hospital over a 10-year period (1999–2008).Results:Twenty-one children underwent 22 parotidectomies, of which six were total. The following pathology was encountered: atypical mycobacterial infection (8.38 per cent), pleomorphic adenoma (4.19 per cent), lymphatic malformation (2.10 per cent), haemangioma (2 per cent), first branchial cleft anomaly (2 per cent), follicular non-Hodgkin's lymphoma (2 per cent) and lipoblastoma (1.5 per cent). No cases of permanent facial nerve palsy occurred. Mild transient facial nerve palsy occurred in five patients (23 per cent), gustatory sweating in four (19 per cent) and hypertrophic scarring in three (14 per cent).Conclusion:We discuss the range of parotid pathology found in children, the approach to investigation, the surgical difficulties encountered, and ways to reduce the apparently higher rate of complications encountered. Parotid surgery in children should be concentrated in the hands of a small number of surgeons with a particular interest in this area.

2021 ◽  
Vol 27 (1) ◽  
pp. 59-65
Author(s):  
Kazi Atikuzzaman ◽  
Mushfiqur Rahman ◽  
Naseem Yasmeen

Objective: To evaluate the common complications following parotid surgery. Material & methods: A retrospective study was done from January 2011 to December 2019 in the Department of ENT & Head Neck Surgery, Enam Medical College & hospital, Savar. Sixty (60) patients with both benign & malignant parotid disease underwent surgical treatment was selected for this study. All cases were diagnosed preoperatively by Fine Needle Aspiration Cytology (FNAC). Patients with preoperative facial nerve palsy were excluded from this study. Patients were followed up for six months and per operative & postoperative complications were evaluated. Results: Out of 60 patients, superficial parotidectomy was done in52 (86.67%) patients and total conservative parotidectomy was done in 08 (13.33%) patients. In this study 56 cases were benign and 04 cases were malignant. Among this 41 (68.33%) pleomorphic adenoma, 05 (8.33%) warthin’s tumour, 03 (5%) benign lymphoepithelial cyst, 03(5%) haemangioma, 02(3.33) sialocele, 01(1.67) dermoid and 01 (1.67%) had salivary fistula. All 04(6.67%) malignant cases were diagnosed as mucoepidermoid carcinoma. Majority of pleomorphic adenomas (92.68%) involved the superficial lobe of the gland. Most commonly observed post operative complication was facial nerve paresis (05%), but only 1.67% developed permanent palsy. Others complication includes Hypoesthesia of the greater auricular nerve (05%), Frey’s syndrome (3.33%) & wound infection (3.33%). Conclusion: Facial nerve palsy is the frequent complication after parotid surgery in this study. Surgeons have to pay attention to minimize the risk of complication during parotidectomy. However, this operation continues to be a challenge on account of the wide range of tumours encountered and the variations in size and location and the facial nerve preservation. Bangladesh J Otorhinolaryngol; April 2021; 27(1): 59-65


2019 ◽  
Vol 36 (2) ◽  
Author(s):  
Dr. Atif Hafeez Siddiqui ◽  
Saad Shakil ◽  
Danish ur Rahim ◽  
Irfan Ahmed Shaikh

Background & Objectives: Transient paralysis of facial nerve is seen to vary from 15 % to 66 % in post-parotid surgery. The objective of this study was to find out the complications in post-parotidectomy with regards to facial nerve dysfunction since it is a vital structure encountered in parotid surgeries. Methods: This was a retrospective study through non probability convenient sampling technique carried from September 2010 to January 2019 in the Department of Otorhinolaryngology, Dow University of Health Sciences, Dr. Ruth K.M.Pfau Civil Hospital, Karachi. Clinical data were recorded from 75 patients and out of them 70 patients had undergone surgery with parotid gland tumours and were reported on the morphology, age, sex, surgical procedure and complications, particularly facial nerve dysfunctions. In most cases ante-grade technique was performed to identify the facial nerve, whereas retrograde technique was used in recurring tumours, and in difficult cases. The stimulator of the nerve has not been used. The nature or severity of Facial nerve dysfunction was assessed in terms of either it is, permanent or temporary, total or incomplete in respect to its branches. Results: Among total 75 patients; the mean age was 38.75 ± 9.26 years with male to female ratio of 1:1. Majority of the patients were diagnosed as pleomorphic adenoma, i.e. 78.6% after which 12% were diagnosed as mucoepidermoid carcinoma. 88.6% of patients had superficial parotidectomy and 11.4% of patients had total parotidectomy. About 75% of patients had no complications. 5(7.1%) patients had complete facial nerve palsy. Damage to the mandibular, buccal and temporozygomatic branch was observed in 10(14%), 2(3%) and 1(1.4%) patients respectively. Conclusion: The most prevalent benign parotid tumour in this study was pleomorphic adenoma. After performing parotid surgery, it was predicted that the rate of complications related to the facial nerve injury was reduced as compared to the previous studies. doi: https://doi.org/10.12669/pjms.36.2.1706 How to cite this:Siddiqui AH, Shakil S, Danish-ur-Rahim, Shaikh IA. Post parotidectomy facial nerve palsy: A retrospective analysis. Pak J Med Sci. 2020;36(2):---------. doi: https://doi.org/10.12669/pjms.36.2.1706 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


2012 ◽  
Vol 3 (1) ◽  
pp. 42-44
Author(s):  
Shraddha Jain ◽  
Sunil Kumar ◽  
P.T. Deshmukh ◽  
Dennis Yohannan ◽  
Kavita Sudarshan

2018 ◽  
Vol 4 (5) ◽  
pp. 369-371
Author(s):  
Rajashree U Gandhe . ◽  
Chinmaya P Bhave . ◽  
Avinash S Kakde . ◽  
Neha T Gedam .

2020 ◽  
Vol 6 (1) ◽  
pp. 1-5
Author(s):  
Daichi Fujii ◽  
Hikari Shimoda ◽  
Natsumi Uehara ◽  
Takeshi Fujita ◽  
Masanori Teshima ◽  
...  

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii352-iii352
Author(s):  
Dennis Tak-Loi Ku ◽  
Matthew Ming-Kong Shing ◽  
Godfrey Chi-Fung Chan ◽  
Eric Fu ◽  
Ping-Wa Yau ◽  
...  

Abstract INTRODUCTION Infantile glioblastoma is rare with poor prognosis. Recent molecular study for infantile hemispheric high grade glioma found its association with ALK/ROS1/NTRK/MET pathway. This suggested the potential use of targeted therapy for refractory / relapse patients. CASE: A newborn presented with apnea, CT brain showed intracranial haemorrhage. MRI then showed a left parietal tumour with bleeding and mass effect. Craniotomy achieved subtotal resection. Chemotherapy VCR/CPM alternating with CDDP/VP-16 was given for one year. Patient was stable with static residual tumour during chemotherapy. However patient developed status epilepticus two weeks after off treatment. MRI showed significant tumour progression which required 2nd & 3rd debulking surgery. Molecular assay by nanostring panel showed BRAF-KIAA1549 fusion. MEK inhibitor Trametinib was tried for 3 months and stopped as disease progression. Further molecular assay by RNASeq showed presence of ROS1 fusion (ZCCHC8-ROS1) while absent of BRAF fusion. Patient underwent 4th debulking surgery as impending herniation while waiting for the targeted therapy. It was complicated with right hemiplegia and facial nerve palsy postoperatively. Finally, ROS1 inhibitor Entrectinib was started 2 weeks later. It was well tolerated without significant adverse reaction. Patient made dramatic neurological recovery including improved facial nerve palsy, able to walk unaided and self feed. MRI brain 1 and 3 months after Entrectinib showed interval reduction in residual tumour. Patient is currently progression-free for 6 months. CONCLUSION Early molecular study for infantile glioblastoma is useful to guide novel therapy. Molecular result may varies between different panels or change over time, to be interpreted with caution.


2021 ◽  
Vol 14 (5) ◽  
pp. e242540
Author(s):  
Rahul Kumar Bafna ◽  
Suman Lata ◽  
Anusha Sachan ◽  
Mohamed Ibrahime Asif

Sign in / Sign up

Export Citation Format

Share Document